CLINICAL SUPPLY MANAGEMENT ARTICLES
Post-Acquisition Clinical Supply Chain Risk: Continuity Before Consolidation
Acquisitions can disrupt clinical trial supply when knowledge, decision rights, inventory data, and supplier responsibilities fail to transfer. Learn how to protect continuity.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
During clinical trials, the intricacies of financial management intensify, necessitating advanced ERP functionalities to handle clinical accruals, compliance, and reporting.
-
An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.
-
Discover how the simplification and digitization of clinical supply chain operations enhanced transparency, lowered risks and expenses, and optimized efficiency.
-
This article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
Since the FDA is now encouraging creativity in trial designs, it is important for all stakeholders to adapt processes to follow the science and ultimately bring medicines to patients, faster. This white paper addresses the complexities that come with these trial designs, and how randomization and trial supply management (RTSM) solutions are critical to run flexible, robust, and quality-driven trials.
-
How can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?
-
Sponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.